Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-02-25 @ 9:41 PM
Study NCT ID:
NCT02410551
Status:
TERMINATED
Last Update Posted:
2018-10-30
First Post:
2015-04-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Myeloproliferative Diseases | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Myeloproliferative Diseases | View |
| None | Myeloproliferative Neoplasms | View |
| None | MPN | View |
| None | Myelofibrosis | View |
| None | Polycythemia vera | View |
| None | PV | View |
| None | Essential thrombocythemia | View |
| None | Allogeneic stem cell transplantation | View |
| None | Allo TP | View |
| None | Pacritinib | View |
| None | Busulfan | View |
| None | Busulfex | View |
| None | Myleran | View |
| None | Questionnaires | View |
| None | Surveys | View |
| None | Phone calls | View |